Early adopters of health information technology have been creating electronic health records for over 10 years. With the creation of the Health Information Technology for Economic and Clinical Health (HITECH) Act and its incentives, the pace of clinical data accumulation is accelerating.
Nearly as many American men as women may suffer from interstitial cystitis/bladder pain syndrome (IC/BPS) symptoms. And more men may have IC/BPS symptoms than have chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) symptoms, new data suggest.
Photoselective vaporization of the prostate (PVP) and transurethral resection of the prostate (TURP) have no difference overall in intermediate-term functional outcomes for surgical treatment of lower urinary tract symptoms secondary to BPH.
The decisions by the men and women who are elected will determine whether physicians who treat Medicare are fairly reimbursed; whether the Independent Payment Advisory Board (IPAB) is allowed to continue; and even how government agencies, task forces, and advisory boards that make recommendations on specific testing and treatment protocols are allowed to function.
Hospital adoption of robotic technology leads to an increase in overall volume of radical prostatectomy cases and has a positive impact on patient morbidity.
An interim analysis of a validation study suggests that urine prostate cancer antigen 3 (PCA3) levels and urine TMPRSS2:ERG (T2:ERG) have additive utility in predicting clinically significant prostate tumor volume, and their use together may enhance the selection and monitoring of candidates with low-volume/low-grade disease for active surveillance.
A robot-assisted laparoscopic radical prostatectomy costs 40% more than a retropubic radical prostatectomy, according to a review of hospital data from one state.
Higher costs without greater benefits means that robotic procedures are at risk of not being supported by efforts to control health care costs.
Experimenting with human prostate cancer cells and mice, cancer-imaging experts at Johns Hopkins University, Baltimore say they have developed a method for finding and killing malignant cells while sparing healthy ones.
A team of disease experts and health economists at Johns Hopkins University, Baltimore warns that steadily declining rates of U.S. infant male circumcision could add more than $4.4 billion in avoidable health care costs if rates over the next decade drop to levels now seen in Europe.
A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to physicians at Duke Cancer Institute, Durham, NC.
Screening for prostate cancer has significant drawbacks, but limited screening could be beneficial, according to an analysis of results from a large European study.
About 40% of urologists report symptoms of burnout, a recent national survey of more than 7,000 physicians finds.
PODCAST Efficacy and safety study comparing Oxybutynin 3% topical gel vs. placebo in adults with Overactive Bladder Syndrome.
Two companies with products in the urology market have signed new distribution agreements.
Due to manufacturing issues, a formulation of the bladder cancer treatment bacillus Calmette-Guérin is currently unavailable from one manufacturer.
Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments when treated at a urology-owned radiation oncology practice versus other facilities, according to a recent study.
Robot-assisted radical prostatectomy appears to provide better functional results for incontinence and potency, according to the authors of a study from Turin, Italy.
Researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center in New York have successfully developed and tested a new prostate cancer screening method.
Fesoterodine fumarate (Toviaz) appears to reduce urge urinary incontinence in patients with overactive bladder who had a suboptimal response to tolterodine tartrate extended release (Detrol LA), according to a phase IV study.
The impact of the proposed Centers for Medicare & Medicaid Services payment cuts to radiation oncology could severely impact community-based cancer care across the country, according to a recent survey from the American Society for Radiation Oncology.
As a man's waistline grows, so can his experience with sexual dysfunction and frequent urination, report researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center, New York.
A team of scientists has discovered a key factor that drives chemotherapy resistance
Multidisciplinary care is associated with increased selection of active surveillance in men with low-risk prostate cancer, according to a recent study.
The increase in the use of magnetic resonance imaging and computed tomography for patients in the U.S. slowed to between 1% and 3% per year between 2006 and 2009, ending a decade of growth that had exceeded 6% annually, according to a study published online in Health Affairs (July 25, 2012).
Pregabalin (Lyrica) capsules do not affect reproductive function in healthy males when compared with placebo, according to results from a study conducted as a post-approval commitment required by the FDA.
A new, nationwide survey of U.S. physicians shows that 42% of urologists say they will retire by 2022.
Researchers from the University of California, San Diego and the University of Tennessee, Memphis, have identified a link between total nephrectomy and erectile dysfunction.
Eliminating the PSA test would be taking a big step backwards and would likely result in rising numbers of men with metastatic cancer at the time of diagnosis, according to a recent analysis.